The FDA believes that an experimental therapy for Huntington’s disease from UniQure wasn't providing benefit for patients, a senior official told STAT.
A new "Make Europe Healthy Again" movement ties U.S. MAHA figures to European anti-vaccine and far-right networks, raising public health concerns.
The FDA's decision on a chatbot for patients recovering from surgery could offer clues on how the agency plans to regulate ...
6 core challenges that researchers must consider as the race to create models that are ever closer to real human embryos ...
CMS said Elevance had "substantial and persistent noncompliance" with requirements to submit information about its customers.
Aetna, the health insurance subsidiary of CVS Health, stopped selling Affordable Care Act plans this year. The company said its ACA members had too many medical claims, with CEO David Joyner noting ...
Meanwhile, 93-year-old vaccine legend Stanley Plotkin is watching vaccination rates slip and calling the anti-vaccine turn inside government what he thinks it is: “stupid” and “immoral.” Also, a ...
Stanley Plotkin, 93, has been so influential to the development of vaccines that they named the field’s go-to textbook after ...
The most-favored nation drug pricing deals the Trump administration reached with 16 drugmakers end after three years in some cases, according to SEC filings ...
UniQure said Monday that plans to seek approval for its Huntington’s disease treatment with the Food and Drug Administration ...
HHS's OIG uncovered $285.2 million in improper and potentially improper payments to clinicians of an autism therapy called applied behavior analysis, it said.
S Stanley Plotkin recalls a night in 1957, during his pediatrics internship, when a father brought a gravely ill toddler into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results